MP68-20 EXPRESSION OF PDL1 (B7-H1) BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY IN UROTHELIAL CARCINOMA.

Ajjai Alva(Michigan Medicine), Rohit Mehra(University of Michigan–Ann Arbor), Tianyu Zhan(Ann Arbor Center for Independent Living), Hong Xiao(Fujian Medical University), Andrew S. McDaniel(Ann Arbor Center for Independent Living), Arul M. Chinnaiyan(University of Michigan), Hui Jiang(Ann Arbor Center for Independent Living), Cheryl Lee(Agency for Science, Technology and Research)
The Journal of Urology
March 31, 2015
10.1016/j.juro.2015.02.2482
Cited by 0

Related Papers

Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
The polycomb group protein EZH2 is involved in progression of prostate cancer
|Nature|2002|2.7k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
|Journal of Clinical Investigation|2002|915
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818